National Microbiology Framework - Lot 3 Manufacturing, Product Development and Commercialisation

Contract summary

Industry

• Medical equipments, pharmaceuticals and personal care products - 33000000

• Medical equipments - 33100000

• Diagnostic devices - 33124100

Location of contract

Any region

Value of contract

£2,500,000,000

Procurement reference

tender_241726/956309

Published date

24 April 2021

Closing date

7 December 2020

Closing time

12pm

Contract start date

9 April 2021

Contract end date

8 April 2023

Contract type

Service contract

Procedure type

Open procedure (above threshold)

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

No

---

Description

Lot 3 is for the manufacturing, product development and commercialisation of diagnostic and/or therapeutic products for the purpose of research, experimentation, study, development or to establish commercial viability or to recover research and development costs.

Please note that this Award Notice is for Lot 3, however the Framework Agreement encompasses the following four lots:
- Lot 1: Diagnostic Goods and Services
- Lot 2: Research and Development Goods and Services
- Lot 3: Manufacturing, Product Development and Commercialisation
- Lot 4: Clinical Laboratory Diagnostic Testing Services

---

More information

Attachments

• National_Microbiology_Framework_Agreement_Lot 3.pdf
• Tender notice
• n/a

• Schedule 6 - Commercial Schedule Lot 3.xlsx
• Tender notice
• n/a

Additional text

The term of the framework is for an initial 2 years with options to extend by up to a further 2 years.

The value attributed to each Lot is an approximate estimate only, the actual values will be to such level as those purchasing under the Framework Agreement consider necessary to provide suitable requirements.

The scope of this Framework Agreement covers Goods and Services that are subject to rapid and frequent improvements, advancements and new scientific and technical developments. Therefore, to keep this Framework Agreement in line with the latest market and scientific developments so as to ensure that patients and other end users have ongoing access to state of the art diagnostics for the duration of this Framework Agreement successful Suppliers will be able to propose new and/or updated Goods and/or Services to be added to a Supplier's range under the Framework Agreement if one or more of the following circumstances apply:

- Where the proposed updated Goods or Services fall within the general scope of this procurement as set out as part of this OJEU Contract Notice (i.e. fall within an existing main or supplementary CPV code as may be referred to in this Contract Notice and/or the description sections of this Contract Notice);
- Where the proposed new Goods or Services fall within the broad categories of Goods or Services covered by this Framework Agreement (i.e. fall within an existing main or supplementary CPV code as may be referred to in this Contract Notice and/or the broad categories of Goods and/or Services referred to in any of the description sections of this Contract Notice), but are new to the market. For the avoidance of doubt, for the purposes of any testing services, this will allow Suppliers to offer new types of tests, new test kits, related new equipment / products, related new consumables and related new Services as and when they become available during the duration of the Framework Agreement provided they fall within an existing main or supplementary CPV code as may be referred to in this Contract Notice and/or the broad categories of Goods and/or Services referred to in any of the description sections of this Contract Notice);
- Where the proposed new or updated Goods or Services reflect a product or service line extension (i.e. are new, modified or updated products or services in the same category of Goods or Services already supplied by a Supplier under this Framework Agreement); or
- Where the proposed new or updated Goods or Services reflect a range extension (i.e. are new, modified or updated products or services that reflect an expansion of the Supplier's range in the same category of Goods or Services already supplied by a Supplier under this Framework Agreement).

---

Award information

Awarded date

12 March 2021

Contract start date

9 April 2021

Contract end date

8 April 2023

Total value of contract

£2,500,000,000

This contract was awarded to 9 suppliers.

AusDiagnostics UK Limited

Bio-Techne Ltd

Europlaz Technologies Ltd

Immensa Health Clinic Ltd

Life Technologies Ltd

Qiagen Ltd

Randox Laboratories Ltd

Thermo Fisher Diagnostics Ltd

Yourgene Health UK Limited

---

About the buyer

Address

61 Colindale Avenue,
London
NW9 5EQ
England

Email

srm.scientific@phe.gov.uk